Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gibb

Showing results (291-300 of 368) with videos related to

Pageof 37
Sort By:
Trials|December 22, 2018
Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP)James A Seddon, Anthony J Garcia-Prats, Susan E Purchase, et al.
Neuroimage|April 19, 2020
Neuroimaging young children and associations with neurocognitive development in a South African birth cohort studyCatherine J Wedderburn, Sivenesi Subramoney, Shunmay Yeung, et al.
BMC Medicine|April 29, 2014
Phase II trial of standard versus increased transfusion volume in Ugandan children with acute severe anemiaPeter Olupot-Olupot, Charles Engoru, Jennifer Thompson, et al.
The Lancet. Infectious Diseases|October 21, 2015
Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trialVeronica Mulenga, Victor Musiime, Adeodata Kekitiinwa, et al.
Antimicrobial Agents and Chemotherapy|September 26, 2025
Population pharmacokinetics of ritonavir as a booster of lopinavir, atazanavir, or darunavir in African children with HIVLufina Tsirizani, Hylke Waalewijn, Alexander Szubert, et al.
Lancet (London, England)|April 23, 2011
Risk of triple-class virological failure in children with HIV: a retrospective cohort study, Hannah Castro, Ali Judd, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2018
Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY TrialFrank A Post, Alexander J Szubert, Andrew J Prendergast, et al.
BMC Medicine|August 1, 2015
Predicting mortality in sick African children: the FEAST Paediatric Emergency Triage (PET) ScoreElizabeth C George, A Sarah Walker, Sarah Kiguli, et al.
BMJ Open|May 25, 2019
Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT)Mark D Lyttle, Julia A Bielicki, Sam Barratt, et al.
The Journal of Infectious Diseases|August 15, 2018
Microbial Translocation Does Not Drive Immune Activation in Ugandan Children Infected With HIVFelicity C Fitzgerald, Edouard Lhomme, Kathryn Harris, et al.
Pageof 37

Showing results (291-300 of 368) with videos related to

Sort By:
Pageof 37
Trials|December 22, 2018
Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP)James A Seddon, Anthony J Garcia-Prats, Susan E Purchase, et al.
Neuroimage|April 19, 2020
Neuroimaging young children and associations with neurocognitive development in a South African birth cohort studyCatherine J Wedderburn, Sivenesi Subramoney, Shunmay Yeung, et al.
BMC Medicine|April 29, 2014
Phase II trial of standard versus increased transfusion volume in Ugandan children with acute severe anemiaPeter Olupot-Olupot, Charles Engoru, Jennifer Thompson, et al.
The Lancet. Infectious Diseases|October 21, 2015
Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trialVeronica Mulenga, Victor Musiime, Adeodata Kekitiinwa, et al.
Antimicrobial Agents and Chemotherapy|September 26, 2025
Population pharmacokinetics of ritonavir as a booster of lopinavir, atazanavir, or darunavir in African children with HIVLufina Tsirizani, Hylke Waalewijn, Alexander Szubert, et al.
Lancet (London, England)|April 23, 2011
Risk of triple-class virological failure in children with HIV: a retrospective cohort study, Hannah Castro, Ali Judd, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2018
Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY TrialFrank A Post, Alexander J Szubert, Andrew J Prendergast, et al.
BMC Medicine|August 1, 2015
Predicting mortality in sick African children: the FEAST Paediatric Emergency Triage (PET) ScoreElizabeth C George, A Sarah Walker, Sarah Kiguli, et al.
BMJ Open|May 25, 2019
Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT)Mark D Lyttle, Julia A Bielicki, Sam Barratt, et al.
The Journal of Infectious Diseases|August 15, 2018
Microbial Translocation Does Not Drive Immune Activation in Ugandan Children Infected With HIVFelicity C Fitzgerald, Edouard Lhomme, Kathryn Harris, et al.
Pageof 37